Sobi's Orfadin® oral suspension granted European patent
Swedish Orphan Biovitrum AB (publ) (Sobi) announced that the European Patent Office (EPO) has decided to grant a European patent for the Orfadin® (nitisinone) oral suspension formulation
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Paediatrics Practical therapeutics Legislation & regulation Hepatic disorders Nephrology Patient care hereditary tyrosinaemia type-1 HT-1 Latest News nitisinone oral suspension formulation orfadin Source Type: news